| Prev Close | 40.16 |
| Day Low/High | 38.44 / 40.66 |
| 52 Wk Low/High | 24.21 / 59.25 |
| Avg Volume | 4.92M |
Canopy Growth Corp. (CGC)
40.57
NYSE : Process Industries
| Exchange | NYSE |
| Shares Outstanding | 343.58M |
| Market Cap | 13.93B |
| EPS | -0.30 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Jim Cramer: Is This as Good as It Gets?
Will it be too painful to stick around while you wait for the Fed to change course?
After Sears, Is J.C. Penney Next to Collapse?
This is a stock with a terrible chart and questionable financials.
Canopy Growth Is Poised to Explode to the Upside
Let's look at the charts and technical indicators.
Play a Potential Altria Pivot Into Pot
The time to scoop up Altria is now, not when some type of official announcement is made.
Canopy Growth and 4 Other Cannabis Stocks That Look Good Here
These stocks offer some diversification or unique features in the legal-weed space.
Chart of the Day: Constellation's Canopy Growth Engine
Canopy Growth could be Constellation's next big growth engine.
Constellation Shares Soar on Thursday
Shareholders enjoyed a crisp day of gains after Constellation cracked open a great earnings report pre-market.
Constellation Shareholders Cautious About the Company's Big Debt Burden
Investors and experts need more time before they go all in on cannabis.
Analysts, Traders Bullish on Constellation as it Shatters Earnings Estimates
Market experts are abuzz over Constellation's potential new inroads into the cannabis market.
Down the Marijuana Rabbit Hole: 5 Companies to Consider
It's too easy to lump all cannabis-related stocks into the moniker "marijuana." Like many other sectors, there are differentiators underneath the same way we see in semiconductors or retail or even energy. As you go down the marijuana rabbit hole, ...
Constellation Brands Is a Bright Star on a Down Day
With STZ's earnings beat and the potential of the CGC investment, investors are willing to pay a premium.
Want to Buy Constellation Brands Stock Today? Read On
I have no problem blessing an investment in this name with the appropriate steps taken toward risk management.
Constellation Brands Buzzes on Raised Guidance, Growth Engines
Constellation looks to wine, beer, and cannabis to take it higher.
7 Smart Ways to Invest in Cannabis Stocks and Not Get Burned
There are several avenues to invest in the potential cannabis boom -- recreational plays; medical plays; and companies that have a lot to gain from the industry but aren't reliant upon it for success.
Tilray's $400 Million Convertible Bond Private Offering
I have the honor and pleasure of book-ending your week away from Doug. On Friday, we'll get non-farm payroll and the unemployment, so I don't put much stock in the data coming this Thursday morning. Instead, I want to start off the day talking abou...
Two Cheers for Corona and Cannabis: Constellation Jumps on Earnings
Constellation looks like a star today after beating expectations.
Cannabis Shorts: Is There Enough Liquidity?
Before you short cannabis names, read this.
Facebook Battles Negative Sentiment and a Weak Chart
The market is in no mood to give the benefit of the doubt to a stock acting as poorly as Facebook.
Cannabis Could Disrupt the Lucrative Market for Painkillers
Painkiller manufacturers might see their profits hurt by medical cannabis in the near future.
Cannabis-Related Products Could Be Your Dog's Best Friend (And Your Portfolio's)
Expert says weed-related products for pets could become a $55 billion-a-year business.
Canopy Growth CEO: Traditional Firms Will See They Must Get Into Legal Cannabis
The only other option is 'to fearfully wait' for the legal-weed industry to expand.
Despite Taking Some Weed, Constellation Brands Charts Are Still Bearish
It is entirely possible that a business relationship with Canopy Growth will help Constellation Brands, but the charts currently suggest further risk for the beverage company.
Canopy Growth Could See New Highs: Here's How to Trade This Hot Cannabis Stock
A look at CGC's charts and our latest strategy.
Canopy Growth CEO Sees Dot-Com-Like Bust for Many Weed Stocks
'There's too much hype too soon,' Canopy Growth chief Bruce Linton says.
Jim Cramer: Reefer Madness
Tilray's a disruptive company for many industries.
If You Must Trade Tilray, Use This Options Play: Market Recon
Covered calls may be the best bet -- or wait for a dip.
Tilray Closes up 38% After Wild Trading Day
Shares were up 94% and down 2.3% in the same session.
Tilray and Other Cannabis Firms Have Even More Catalysts on the Horizon
Canadian marijuana legalization and U.S. approval of industrial hemp are coming.
Jim Cramer: The Tilray Short Squeeze
Cannabis companies should be taking advantage of the mania to raise money.
Tilray's Sales Are Irrelevant and Its Charts Don't Matter
Don't try to explain the stock's meteoric rise on a fundamental or technical basis, because it defies both.
